These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32319474)

  • 21. Characterization of a UL49-null mutant: VP22 of herpes simplex virus type 1 facilitates viral spread in cultured cells and the mouse cornea.
    Duffy C; Lavail JH; Tauscher AN; Wills EG; Blaho JA; Baines JD
    J Virol; 2006 Sep; 80(17):8664-75. PubMed ID: 16912314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice.
    Pifarré MP; Berra A; Coto CE; Alché LE
    Exp Eye Res; 2002 Sep; 75(3):327-34. PubMed ID: 12384095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea.
    Tumpey TM; Chen SH; Oakes JE; Lausch RN
    J Virol; 1996 Feb; 70(2):898-904. PubMed ID: 8551629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis.
    Thomas J; Kanangat S; Rouse BT
    J Interferon Cytokine Res; 1998 Sep; 18(9):681-90. PubMed ID: 9781806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.
    Rowe AM; Yun H; Treat BR; Kinchington PR; Hendricks RL
    J Immunol; 2017 Feb; 198(4):1706-1717. PubMed ID: 28062697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
    Noisakran SJ; Carr DJ
    Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes Simplex Virus Keratitis.
    Harris KD
    Home Healthc Now; 2019; 37(5):281-284. PubMed ID: 31483360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical herpes simplex keratitis: frequency, clinical presentations and treatment results.
    Erdem E; Harbiyeli İİ; Öztürk G; Oruz O; Açıkalın A; Yağmur M; Ersöz R; Yarkın F
    Int Ophthalmol; 2020 Mar; 40(3):659-665. PubMed ID: 31754891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.
    Royer DJ; Gurung HR; Jinkins JK; Geltz JJ; Wu JL; Halford WP; Carr DJJ
    J Virol; 2016 Jun; 90(11):5514-5529. PubMed ID: 27030264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.
    Rajasagi NK; Bhela S; Varanasi SK; Rouse BT
    J Leukoc Biol; 2017 Nov; 102(5):1159-1171. PubMed ID: 28584076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of human cornea organotypic cultures to study herpes simplex virus type 1 (HSV-1)-induced inflammation.
    Drevets P; Chucair-Elliott A; Shrestha P; Jinkins J; Karamichos D; Carr DJ
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1721-8. PubMed ID: 26047535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis.
    Remeijer L; Maertzdorf J; Buitenwerf J; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):358-63. PubMed ID: 11818377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.
    Asbell PA; Epstein SP; Wallace JA; Epstein D; Stewart CC; Burger RM
    Cornea; 1998 Sep; 17(5):550-7. PubMed ID: 9756451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein C of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneas.
    Drolet BS; Mott KR; Lippa AM; Wechsler SL; Perng GC
    Curr Eye Res; 2004; 29(2-3):181-9. PubMed ID: 15512965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced detection of herpes simplex virus from ocular specimens of herpetic keratitis patients.
    Pramod NP; Gopalakrishnan V; Mohan R; Chandriga S; Anandakannan K; Menon T; Thyagarajan SP
    Indian J Pathol Microbiol; 1998 Jan; 41(1):49-53. PubMed ID: 9581077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.
    Asbell PA
    Trans Am Ophthalmol Soc; 2000; 98():285-303. PubMed ID: 11190029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic vaccination with vhs(-) herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice.
    Keadle TL; Laycock KA; Morris JL; Leib DA; Morrison LA; Pepose JS; Stuart PM
    J Gen Virol; 2002 Oct; 83(Pt 10):2361-2365. PubMed ID: 12237416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of polyclonal antibodies for treatment of ocular herpes simplex infection.
    Epstein SP; Nurozler M; Smetana CR; Asbell PA
    Cornea; 2001 Jul; 20(5):495-500. PubMed ID: 11413405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A-5021: a new acyclovir analogue inhibits murine herpetic keratitis.
    Itahashi M; Higaki S; Sugahara D; Sugioka K; Deai T; Takao K; Hayashi K; Shimomura Y
    Cornea; 2008 Apr; 27(3):334-8. PubMed ID: 18362663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetrandrine potently inhibits herpes simplex virus type-1-induced keratitis in BALB/c mice.
    Hu S; Dutt J; Zhao T; Foster CS
    Ocul Immunol Inflamm; 1997 Sep; 5(3):173-80. PubMed ID: 9326762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.